Category: pharmacological
Aliases: Sprycel
Multi-kinase inhibitor: BCR-ABL, SRC family, EPHA2, PDGFR, KIT. In oncology, treats Ph+ ALL + CML (imatinib-resistant). Recent research interest as a senolytic — paired with quercetin, selectively clears senescent cells in preclinical + early human (IPF, diabetic kidney disease) trials.
PO: 4h